Evolus (EOLS) Invested Capital (2018 - 2025)
Evolus (EOLS) posted Invested Capital of $33.1 million for Q1 2025, down 1.4% on a QoQ basis from $33.6 million in Q4 2024, and down 6.55% year-over-year from $35.4 million in Q1 2024.
Evolus (EOLS) Invested Capital (2018 - 2025) Analysis & Trends
Evolus' Invested Capital history runs 8 years deep, the most recent figure standing at $33.1 million for Q1 2025.
- Quarterly Invested Capital fell 6.55% year-over-year to $33.1 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $33.1 million (down 76.06% YoY) and the FY2024 annual result came in at $33.6 million, down 7.32% from the prior year.
- Invested Capital was $33.1 million for Q1 2025 at Evolus, down from $33.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $39.8 million in Q4 2022 and bottomed at $33.1 million in Q1 2025.
- A 5-year average of $37.5 million and a median of $38.7 million in 2021 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital climbed 23.81% — and 2024, when it retreated 11.51%.
- Evolus' Invested Capital stood at $39.4 million in 2021, then increased by 1.08% to $39.8 million in 2022, then declined by 9.16% to $36.2 million in 2023, then decreased by 7.32% to $33.6 million in 2024, then dropped by 1.4% to $33.1 million in 2025.
- Business Quant data shows EOLS's Invested Capital at $33.1 million in Q1 2025, $33.6 million in Q4 2024, and $34.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 33.08 Mn |
| Dec 31, 2024 | 33.55 Mn |
| Sep 30, 2024 | 34.60 Mn |
| Jun 30, 2024 | 34.60 Mn |
| Mar 31, 2024 | 35.40 Mn |
| Dec 31, 2023 | 36.20 Mn |
| Sep 30, 2023 | 38.70 Mn |
| Jun 30, 2023 | 39.10 Mn |
| Mar 31, 2023 | 39.60 Mn |
| Dec 31, 2022 | 39.85 Mn |
| Sep 30, 2022 | 39.00 Mn |
| Jun 30, 2022 | 39.20 Mn |
| Mar 31, 2022 | 39.30 Mn |
| Dec 31, 2021 | 39.43 Mn |
| Sep 30, 2021 | 39.00 Mn |
| Jun 30, 2021 | 38.70 Mn |
| Mar 31, 2021 | 38.30 Mn |
| Dec 31, 2020 | 38.10 Mn |
| Sep 30, 2020 | 31.50 Mn |
| Jun 30, 2020 | 35.10 Mn |